IFP Advisors’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
Other funds holding LSTA
BCM
CW
IFP Advisors's LSTA Position: Q4 2023 in Review
IFP Advisors sold out of Lisata Therapeutics (LSTA) in Q4 2023, closing a stake of 10 shares — an estimated $21 sold.
IFP Advisors first reported a position in LSTA in Q4 2015 and held it in 28 quarters. The position peaked at $4K in Q2 2018. 22 funds tracked by Wall St. Rank hold LSTA as of Q4 2023.
- IFP Advisors reported no remaining Lisata Therapeutics position as of Q4 2023 after selling out during the quarter.
- IFP Advisors sold 10 Lisata Therapeutics shares in Q4 2023, an estimated $21.
- IFP Advisors first reported a position in Lisata Therapeutics in Q4 2015 and held it in 28 quarters.
- IFP Advisors's Lisata Therapeutics position peaked at $4K in Q2 2018.
- 22 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2023.
Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.